SOLNA, Sweden--(BUSINESS WIRE)--Regulatory News:
Aerocrine AB (STO:AEROB) (OMX Nordic Exchange: AERO) today announced the positive outcome of its complaint against Medisoft S.A. filed at the Liège Commercial Court, Belgium.
On 14 October 2011, Aerocrine started infringement proceedings against the Belgian company Medisoft S.A. before the Liège Commercial Court, on the basis of four of Aerocrine´s patents. Medisoft challenged both infringement and the validity of the patents as part of its defense. The oral hearings on the merits took place during the spring 2012.